Rechtszaak gericht tegen Lonza, producent van CASGEVY, 's werelds eerste goedgekeurde CRISPR-gebaseerde gentherapie Tweede Europese rechtszaak, na het Verenigd Koninkrijk,

Demanda contra Lonza, fabricante neerlandés de la primera terapia génica basada en CRISPR aprobada a nivel mundial, CASGEVY Segunda acción

Lawsuit filed against Lonza, the Dutch manufacturer of the world's first CRISPR-based genome editing therapy, CASGEVY Second European action following

In the past, every American could recite Smokey Bear’s slogan: “Only you can prevent forest

This week’s agricultural events include the Food For … with like-minded women in agriculture.

The Business Research Company’s Polyethylene (PE) Pipes For Water Conduction Global Market Report 2025 – Market Size, Trends, And Forecast

Scoot Expands Travel Flexibility with Dohop: New Interline Platform Connects Passengers to Over 30 Destinations Across Europe and Indonesia In August

TORONTO, ONTARIO, CANADA, September 8, 2025 /⁨EINPresswire.com⁩/ -- Global clean energy solutions provider BLUETTI today announced the launch of its

MANCHESTER, UNITED KINGDOM, September 8, 2025 /⁨EINPresswire.com⁩/ -- Charles Vermont, an established independent UK retailer of designer womenswear, continues to

Seamless integration automates guest communications to boost engagement, reputation, and revenue for lodging operators. CALGARY, CANADA, September 8, 2025 /⁨EINPresswire.com⁩/ --